GLP-1 medications improve glucose control and reduce systemic inflammation, which may reduce glycation stress on collagen
It is important to note that no licensed dosage has been established , as retatrutide has not yet received regulatory approval from any medicines authority
Despite the significant burden of disease, effective pharmacological options remain limited, leaving lifestyle interventions based on dietary modification and physical activity as the mainstay of clinical management [6]
However, the large molecular size of GLP-1 analogues presents significant formulation challenges for transdermal delivery
These agents stimulate glucose-dependent insulin secretion and suppress inappropriate glucagon release, thereby improving glycemic control
However, for qualified patients, they may help support appetite control, earlier fullness, reduced food intake, and greater consistency with a medical weight-loss plan